$SRRK 8-K SEC Filings

Filed On	Filing
15 Sep 2026	8-K: Regulation FD Disclosure On September 14, 2026, Scholar Rock Holding Corporation (the “Company”) hosted a live audio webcast (the “Investor Call”) announcing that the U.S. Food and Drug Administration (“FDA”) has approved ISEMBYLD™ (apitegromab-mstn) for the tre...
14 Sep 2026	8-K: Regulation FD Disclosure; Other Events Scholar Rock Announces FDA Approval of ISEMBYLD™ (apitegromab-mstn), the First and Only Muscle-Targeted Treatment for Children and Adults with Spinal Muscular Atrophy (SMA)
06 Aug 2026	8-K: Other Events
06 Aug 2026	8-K: Results of Operations and Financial Condition
05 Jun 2026	8-K: Submission of Matters to a Vote of Security Holders
07 May 2026	8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
31 Mar 2026	8-K: Regulation FD Disclosure; Other Events
03 Mar 2026	8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
12 Jan 2026	8-K: Results of Operations and Financial Condition; Regulation FD Disclosure +1 more
02 Dec 2025	8-K: Other Events
14 Nov 2025	8-K: Other Events
14 Nov 2025	8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
14 Oct 2025	8-K: Other Events
23 Sep 2025	8-K: Regulation FD Disclosure; Other Events
06 Aug 2025	8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
18 Jun 2025	8-K: Regulation FD Disclosure; Other Events
03 Jun 2025	8-K: Changes in Registrant's Certifying Accountant
23 May 2025	8-K: Submission of Matters to a Vote of Security Holders
14 May 2025	8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
12 May 2025	8-K: Changes in Registrant's Certifying Accountant

Comments